Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4545253 | 0.79 | KDM4E (0.37) | KDM4EALDH1A1LMNA | |
| SCHEMBL9317589 | 0.76 | KDM4E (0.38) | KDM4EALDH1A1LMNATHRB | |
| SCHEMBL16704800 | 0.72 | KDM4E (0.35) | KDM4EALDH1A1LMNA | |
| SCHEMBL21215002 | 0.72 | KDM4E (0.35) | KDM4EALDH1A1LMNA | |
| SCHEMBL4545263 | 0.72 | KDM4E (0.39) | KDM4EALDH1A1LMNATHRB | |
| SCHEMBL2014878 | 0.72 | KDM4E (0.35) | KDM4EALDH1A1LMNA | |
| SCHEMBL2458229 | 0.72 | KDM4E (0.35) | KDM4EALDH1A1LMNATHRB | |
| SCHEMBL16705159 | 0.72 | KDM4E (0.35) | KDM4EALDH1A1LMNA | |
| SCHEMBL2020010 | 0.72 | KDM4E (0.30) | KDM4E | |
| SCHEMBL18609464 | 0.72 | KDM4E (0.37) | KDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8367849-B2 | Production method for sultone derivatives | KURARAY CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8367849-B2 | Production method for sultone derivatives | KURARAY CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8367849-B2 | Production method for sultone derivatives | KURARAY CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8168349-B2 | Fuel cell-purpose electrolyte material and production method therefor | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20110160465-A1 | PRODUCTION METHOD FOR SULTONE DERIVATIVES | KURARAY CO., LTD (JP) | 2011-06-30 | — | — | US | disclosed |
| US-20110160465-A1 | PRODUCTION METHOD FOR SULTONE DERIVATIVES | KURARAY CO., LTD (JP) | 2011-06-30 | — | — | US | disclosed |
| US-20110160465-A1 | PRODUCTION METHOD FOR SULTONE DERIVATIVES | KURARAY CO., LTD (JP) | 2011-06-30 | — | — | US | disclosed |
| US-20090136819-A1 | Fuel Cell-Purpose Electrolyte Material and Production Method Therefor | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2009-05-28 | — | — | US | disclosed |
| WO-2007096747-A1 | FUEL CELL-PURPOSE ELECTROLYTE MATERIAL AND PRODUCTION METHOD THEREFOR | TOYOTA JIDOSHA KABUSHIKI KAISHA (DE) | 2007-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160465-A1 | PRODUCTION METHOD FOR SULTONE DERIVATIVES | SULT1E1, SULT2A1, SULT1A1 | KDM4E 1041/4885ALDH1A1 45/4885LMNA 4818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.